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Abstract
This paper reports the effect of a-amylase encapsulation on the degradation rate of a starch-based biomaterial. The encapsulation
method consisted in mixing a thermostable a-amylase with a blend of corn starch and polycaprolactone (SPCL), which were processed
by compression moulding to produce circular disks. The presence of water was avoided to keep the water activity low and consequently
to minimize the enzyme activity during the encapsulation process. No degradation of the starch matrix occurred during processing and
storage (the encapsulated enzyme remained inactive due to the absence of water), since no significant amount of reducing sugars was
detected in solution. After the encapsulation process, the released enzyme activity from the SPCL disks after 28 days was found to be
40% comparatively to the free enzyme (unprocessed). Degradation studies on SPCL disks, with a-amylase encapsulated or free in solu-
tion, showed no significant differences on the degradation behaviour between both conditions. This indicates that a-amylase enzyme was
successfully encapsulated with almost full retention of its enzymatic activity and the encapsulation of a-amylase clearly accelerates the
degradation rate of the SPCL disks, when compared with the enzyme-free disks. The results obtained in this work show that degradation
kinetics of the starch polymer can be controlled by the amount of encapsulated a-amylase into the matrix.
! 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
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1. Introduction
The demands for biomaterials with controlled, predict-
able degradation kinetics includes a wide range of biomed-
ical applications, such as resorbable surgical sutures,
matrices for the controlled release of drugs and scaffolds
for tissue engineering [1–4]. In fact, the performance of
many biomaterials depends largely on their degradation
behaviour since the degradation process may affect a range
of events, such as cell growth, tissue regeneration, drug
release, host response and material function.
Biodegradable polymers are materials with the ability of
functioning for a temporary period and subsequently
degrade in physiological conditions, under a controlled
mechanism, into products easily eliminated in the body’s
metabolic pathways.
Several strategies have been developed to obtain bioma-
terials with a controlled degradation rate. Those have been
based on molecular design principles, such as the introduc-
tion of hydrolysable bonds into polymer backbones [5], co-
polymerization and blending techniques [6], crosslinking
[7,8] and surface modification methods [9,10], and inclusion
of certain additives [11–13] into polymeric matrices (e.g.
excipients, drugs, salts, etc.).
An interesting approach has been the development of
polymeric systems with a self-regulated degradation
1742-7061/$ - see front matter ! 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
doi:10.1016/j.actbio.2009.04.039
* Corresponding author. Address: 3B’s Research Group – Biomaterials,
Biodegradables and Biomimetics, University of Minho, Headquarters of
the European Institute of Excellence on Tissue Engineering and Regen-
erative Medicine, AvePark, 4806-909 Taipas, Guimara˜es, Portugal. Tel.:
+351 253 510907; fax: +351 253 510909.
E-mail address: hazevedo@dep.uminho.pt (H.S. Azevedo).
Available online at www.sciencedirect.com
Acta Biomaterialia 5 (2009) 3021–3030
www.elsevier.com/locate/actabiomat
mechanism. In these systems, the degradation process is ini-
tiated and/or controlled under certain environment condi-
tions or in response to cell activities [3,14,15]. For instance,
Hubbell and co-workers [16–18] developed a novel class of
hydrogels that are sensitive to the activity of cell-associated
proteases. This cell-mediated degradation approach consists
in the inclusion of enzymatic recognition sites into polymer
backbones to make the material sensitive to the feedback
provided by the cells involved in the healing response. In this
way, the materials will degrade in response to cellular activ-
ities and the tissues may determine the degradation rate of
the materials rather than the calendar.
Materials to be used in some applications, such as hard-
tissue replacement, must combine adequate mechanical
properties with controlled biodegradability. The material
should degrade while maintaining a specified minimum
mechanical strength to support the formation of new tis-
sue. It may be difficult to achieve the desired combination
of degradation and physical properties in a single material.
In this context, enzyme encapsulation technology can be
used to incorporate hydrolytic enzymes into the polymeric
matrices and then provide systems with controlled degra-
dation. Controlled degradation by enzymatic means pre-
sents several advantages considering the high specificity
of enzymes for their substrates and also because enzyme
activity can be regulated by environmental conditions
(e.g. pH, temperature, the presence of certain substances,
like metal ions) [19]. In addition, the degradation kinetics
can be adjusted by the amount of encapsulated enzyme into
the matrix. For instance, Goldbart et al. [14] developed an
enzymatically controlled responsive drug delivery system
consisting of a starch-based tablet incorporating a non-
active a-amylase and a protein. The enzyme reactivation
was made by the presence of calcium ions (which is known
to be essential for enzyme’s tertiary structure and catalytic
activity) from the medium, which causes the tablet degra-
dation and the concomitant release of the protein.
A basic requirement in enzyme encapsulation technology
is that the integrity of the enzyme structure must be main-
tained during the encapsulation process. This is often a dif-
ficult challenge as most proteins are dependent on a three-
dimensional conformation for their bioactivity and that
conformation can be easily compromised. For instance,
most of the polymers that are used in biomedical applica-
tions are not soluble in water and consequently the protein
is exposed to an organic solvent during the encapsulation
step. Examples of other stress conditions associated with
the manufacture of medical devices, and that may compro-
mise protein integrity, are the high shear forces used during
extrusion processes or to form droplets of the polymer solu-
tion in a continuous phase, exposure to polymer reactions,
high temperature and adverse pH values [20].
Starch is a fully biodegradable material that is readily
available and can easily be modified, therefore constituting
a good material to produce encapsulation matrices [21–
24]. Several starch-based formulations have been prepared
containing encapsulated a-amylase to develop enzymati-
cally controlled drug delivery systems [14,21,24,25]. The
methods used for the preparation of the tablets have been
based mainly on mechanical compression [14,24]. Physical
compression does not allow good adhesion to be obtained
between components, leading to the formation of tablets
without enough mechanical integrity. Starch has thus been
blended with synthetic polymers (polycaprolactone,
poly(lactic acid), poly(butylene succinate adipate, poly(eth-
ylene-co-vinyl alcohol), etc.) to improve its weakness and
obtain better mechanical properties [26–31]. Starch-based
polymers have been studied and proposed as potential mate-
rials to be used in several biomedical applications [32–38],
namely as carriers for drug delivery [36,37], hydrogels and
partially degradable bone cements [37,39], and porous struc-
tures to be used as scaffolds in bone tissue engineering
[33,35]. The susceptibility of these starch polymeric blends
to enzymatic degradation has also been reported [40,41].
The processing conditions of thermoplastics, however,
does not allow the incorporation of biomolecules like pro-
teins or enzymes during processing, since the high tempera-
tures used duringmelt-based processes can cause irreversible
changes to the protein structure, leading to its denaturation.
The use of enzymes with high heat stability can overcome
this obstacle and constitute a good alternative that can effi-
ciently encapsulate enzymes by melting techniques.
In this work, a thermostable a-amylase was encapsu-
lated in a starch matrix (processed by compression mould-
ing) with the aim of tailoring its degradation rate.
2. Materials and methods
2.1. Materials
The material used in this work was a commercially
available thermoplastic starch-based polymer (Z grade
MATER-BI", ZI01U), supplied by Novamont S.P.A.
(Novara, Italy) in granular form, containing starch,
poly(e-caprolactone) (PCL) and plasticizers (glycerol)
[42]. This material is described in several patents [31,42–45],
and is based on native maize starch and PCL with a molec-
ular weight of 118,000 [42]. The properties and characteris-
tics of the starch/PCL blend (SPCL) can be found in
previous publications [46,47]. Soluble potato starch for
measuring a-amylase activity was obtained from Sigma–
Aldrich Inc. (St. Louis, MO, USA).
The encapsulant enzyme was a thermostable a-amylase
supplied in a liquid formulation (SPEZYME" FRED, Gen-
encor International Inc., Rochester, NY,USA) produced by
a genetically modified strain of Bacillus licheniformis.
2.2. Preparation of starch-based matrices: the encapsulation
method
Prior to use, the enzymewas first lyophilized to obtain the
enzyme in powder form. Then the enzyme was mixed with
the polymer powder (previously milled in a high speed mill-
ing equipment) at different weight percentages (0.5% and
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5%, relative to the polymermass) and processed by compres-
sion moulding (P = 4 kg cm!2, T = 90 #C, 20 min) in a
hydraulic press to prepare disks of about 0.25 g (diame-
ter = 1 cm, thickness = 2 mm). A control, without enzyme,
was also prepared. The disks were stored in closed contain-
ers at room temperature (away from excess of heat andmois-
ture) until further use.
2.3. Water uptake studies
To determine the water uptake of the starch-based
matrices, enzyme-free disks (control) were immersed in
2.5 ml of phosphate-buffered saline (PBS) solution
(0.01 M, pH 7.4) and incubated at 4 and 37 #C. The water
uptake for loaded disks (with 0.5% enzyme) was also deter-
mined at 4 #C. The disks were weighed periodically to cal-
culate the percentage of water uptake. Before measuring
the wet weight, any surface water was removed by placing
the disks between two filter papers.
Fig. 1. Concentration of reducing sugars in solution after immersion of
SPCL disks (0.5% encapsulated a-amylase) in PBS (pH 7.4) at 4 #C for
different periods of time. The data points in the figure represent the mean
of three replicates and error bars the standard deviation.
Fig. 2. (A) Evolution of water uptake of SPCL disks (controls) in PBS
(pH 7.4) at 4 and 37 #C for 24 h. (B) Water uptake of SPCL disks (controls
and encapsulated with 0.5% and 5% of a-amylase) after incubation in PBS
(pH 7.4) at 37 #C for 1 week. The data points in the figures represent the
mean of four replicates and error bars the standard deviation.
Fig. 3. a-Amylase release (% active enzyme) from the SPCL disks loaded
with 0.5% a-amylase in PBS (pH 7.4) at 4 #C (A) (see Section 2 for details).
(B) shows the a-amylase release for a period of 4 weeks (672 h). The data
points in the figure represent the mean of three replicates and error bars
the standard deviation.
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2.4. Enzyme release studies
Enzyme release from the starch-based matrices was
determined by placing the SPCL disks, containing 0.5%
of encapsulated a-amylase, in individual tubes containing
2.5 ml of PBS (0.01 M, pH 7.4) solution at 4 #C to mini-
mize enzyme activity (matrix degradation and consequently
release of sugars during the release experiments). Periodi-
cally, 0.5 ml aliquots were collected from the release med-
ium and replaced with an equal volume of fresh buffer.
The activity of released a-amylase was determined by incu-
bating 250 ll of appropriately diluted release medium with
1 ml of substrate solution (1% w/v of a soluble potato
starch in 0.01 M of PBS, pH 7.4) at 37 #C under constant
agitation in a shaking water bath (100 rpm) for 10 min.
The concentration of reducing sugars in the solution was
quantified using the dinitrosalicylic acid (DNS) method
[48] in a microplate reader (Synergy HT, BIO-TEK Instru-
ments, Inc., Winooski, Vermont, USA) at 540 nm and
using a standard curve of glucose. a-Amylase activity was
calculated in terms of U ml!1 (1 U corresponds to 1 lmol
of product formed (reducing sugars as glucose) per min).
The cumulative activity of enzyme released from the disks
was calculated as the percentage of activity that was mea-
sured using fresh enzyme solution at a concentration equiv-
alent to that which would have been obtained if the
encapsulated enzyme was completely released (100%).
2.5. Evaluation of the degradation profile of starch-based
matrix with encapsulated and free a-amylase
The processed disks were placed in 15 ml tubes contain-
ing 2.5 ml of PBS solution (0.01 M, pH 7.4) and incubated
at 37 #C for different periods of time under static condi-
tions (studies with encapsulated enzyme). After this period,
the samples were washed thoroughly with distilled water,
dried at room temperature and stored in a desiccator for
further analysis.
To compare the effect of the encapsulation method on
the enzyme activity, another set of experiments was per-
formed using the same amount of encapsulated enzyme dis-
solved in the buffer solution (studies with free enzyme). The
same experimental procedure was followed as described for
the studies with encapsulated enzyme.
Matrix degradation was assessed by determination of
weight loss and by measuring the concentration of reducing
sugars released into the solution as a result of starch hydro-
lysis by a-amylase. The concentration of reducing sugars in
Fig. 4. Degradation profile of SPCL disks, measured in terms of weight loss (left) and concentration of reducing sugars in solution (right), in the presence
of different percentages (enzyme percentages given in terms of polymer mass) of a-amylase encapsulated (A) or free in solution (B). The data points in the
figure represent the mean of four replicates and error bars the standard deviation.
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solution was measured by the DNS method, as described
previously. The morphology of the sample surface and
interior, before and after degradation, was examined for
all the studied conditions by scanning electron microscopy
(SEM; Leica Cambridge S360, UK). Changes within the
material were analysed by observing the sample cross-sec-
tion obtained by freeze-fracturing in liquid nitrogen. Prior
to SEM observations, the samples were gold sputtered in a
Sputter Coater SC502 (Fisons Instruments, UK).
3. Results
3.1. Encapsulation method
Enzyme encapsulation was performed by a thermome-
chanical process (compression moulding) at 90 #C. Analys-
ing the results shown in Fig. 1, it can be seen that no
noticeable amount of reducing sugars was detected in solu-
tion during 28 days (4 weeks) of immersion of the SPCL
disks loaded with a-amylase (0.5%) in PBS at 4 #C, espe-
cially when compared with the amount of sugars produced
under the same conditions but at higher temperature
(Fig. 4(A)). For instance, at 37 #C, the amount of reducing
sugars found in solution after 1 week was 8.748 ± 4.465
mg ml!1, while at 4 #C the highest concentration of sugars
detected in solution was 0.232 ± 0.038 mg ml!1, and this
only after 4 weeks of incubation. These results show that
at 4 #C the enzyme is not capable of performing any cata-
lytic activity, and this lack of catalytic activity is probably
due to the low temperature. On the other hand, the absence
of sugars in the solution also indicates that during process-
ing there was no hydrolysis of the starch matrix.
3.2. Water uptake studies
The water uptake of control disks in PBS at 4 and 37 #C
is presented in Fig. 2A. Water uptake of SPCL disks
depends on the temperature, and reaches equilibrium
within 2–5 h. In most polymers, water uptake increases
with increased temperatures [49]. The higher water uptake
at 37 #C may be due to the temperature-dependent behav-
iour of the polymers. These differences in water uptake
behaviour of the samples at 4 and 37 #C are expected to
influence the release of the enzyme [49] from the SPCL
Fig. 5. SEM micrographs of the surface of SPCL disks before (A) and after 4 weeks of degradation in PBS (pH 7.4) at 37 #C. Control (B), with 0.5% (C)
and 5% (D) encapsulated a-amylase.
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disks (Fig. 3). The effect of encapsulated enzyme on the
water uptake of the SPCL disks was examined at 4 #C
and is shown in Fig. S1 (Supplementary information). It
can be seen that the loaded disks absorb slightly more
water than the control samples.
Fig. 2(B) shows the water uptake of SPCL disks after
1 week of incubation in PBS at 37 #C, in which higher val-
ues of water uptake are observed. During this incubation
period, there is already evidence of matrix degradation
(Figs. 4 and 6), the degradation effects being more evident
for the samples with the encapsulated enzyme. Internal
hydrolysis of the disk will cause pores to form and conse-
quently increase the matrix permeability, leading to faster
water penetration.
3.3. Enzyme release studies
To assess the enzyme release from the SPCL disks,
release experiments were performed at 4 #C to avoid matrix
degradation and consequently the accumulation of reduc-
ing sugars in the medium. The activity of the released
enzyme was then measured and given as a percentage of
the active enzyme (Fig. 3). After immersion in PBS, the
enzyme starts to be released as a result of enzyme dissolu-
tion that is present at the outermost layer, causing the for-
mation of channels through which water may further
penetrate. The enzyme activity reaches a plateau of 40%
of its original activity (unprocessed enzyme) by about
48 h, after which no further increase is observed. These
results show that the released enzyme is active but that
incomplete release and/or loss of partial activity might
have occurred, since the released enzyme did not reach
100% of the original activity even after 28 days.
3.4. Evaluation of the degradation profile of the starch-based
matrix with encapsulated and free a-amylase
Fig. 4 shows the degradation behaviour of SPCL disks
at pH 7.4 in the presence of a-amylase, encapsulated in
the polymer matrix and free in solution, in terms of weight
Fig. 6. SEM micrographs of the surface of SPCL disks showing the sample morphology in more detail (micrographs at higher magnifications) after
degradation for 1, 4 and 12 weeks in PBS (pH 7.4) at 37 #C. Control (A), with 0.5% (B) and 5% (C) encapsulated a-amylase.
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loss and concentration of reducing sugars. The control
sample exhibits a significant weight loss (about 13%) dur-
ing the first week, but the sample mass tends to remain
almost constant in the following weeks. The rapid weight
loss of the control in the first week is related to the leaching
out of plasticizers (glycerol) used in the blend formulation
[40], since no noticeable amounts of sugars were detected in
solution for the control samples (Fig. 4(A)). With 5% of
encapsulated a-amylase, there is a significant percentage
of weight loss in the first week, with almost all the starch
being hydrolysed in this period. When a lower percentage
of a-amylase is encapsulated (0.5%) the degradation rate
is slower, but complete starch hydrolysis is reached after
8 weeks. Comparing the degradation profile of SPCL cap-
sules in the presence of a-amylase both free in solution and
encapsulated, no significant differences are observed in
either the weight loss or the concentration of reducing
sugars.
The effect of enzyme degradation, in both the encapsu-
lated and the free form, on the surface morphology of
SPCL disks can be observed in the SEM micrographs
shown in Figs. 5–8. Although the incubation in PBS also
causes some erosion on the material surface (Figs. 5 and
6(A)), the incubation of the disks with the encapsulated
a-amylase leads to a highly porous structure. The degrada-
tion effect of the free enzyme (Fig. 8) is not as clear as the
one observed with the encapsulated enzyme, which may be
related with the starch distribution in the blend.
Enzyme hydrolytic activity induces changes in the phys-
icochemical properties of the matrix and, as a result of deg-
radation, the matrix collapses, as can be observed in
Fig. 7(D).
4. Discussion
Previous studies about the thermal properties of the
polymeric blend used in this work [46] showed that the
melting peak of polycaprolactone fraction in the SPCL
blend exhibited an onset temperature at 50.6 #C. Taking
into account the low melting temperature of the SPCL
blend, this material was selected to be used as the encaps-
ulant matrix of a thermostable enzyme.
Fig. 7. SEM micrographs of the cross-section (cryogenic fractures) of SPCL disks before (A) and after degradation for 12 weeks in PBS (pH 7.4) at 37 #C.
Control (B), with 0.5% (C) and 5% (D) encapsulated a-amylase.
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It is known that enzyme activity depends on several fac-
tors, like temperature and water activity [50], and the rate
of enzymatic reactions in insoluble substrates is limited
by the rate at which the enzyme diffuses into the substrate.
In the present study, it is important to minimize the enzyme
activity during processing and storage but also to maintain
its activity after the encapsulation process. By avoiding the
use of water during processing, the water activity is kept
low, minimizing the matrix degradation during this stage.
Fig. 1 shows that when SPCL disks with encapsulated
enzyme (0.5%) were immersed in PBS at 4 #C the amount
of sugars in the solution was negligible for a period of
4 weeks, thus indicating that the enzyme activity was min-
imized during the encapsulation process.
The reactivation of the enzyme can be achieved by enzy-
matic hydration upon water uptake of the solid substrate,
which will act as a trigger for the degradation of the encap-
sulation matrix. After implantation, biomaterials interact
with surrounding fluids by first absorbing water. The water
uptake of the developed disks (with and without encapsu-
lated enzyme) was determined at different temperatures
and for various periods of time (Fig. 2). Water uptake
increased with increasing temperature and also with
increasing amounts of encapsulated enzyme (Fig. S1). Sim-
ilar results were found by different authors [14,21,22], who
also observed differences in water uptake between matrices
with and without encapsulated enzymes. In all the studies,
matrices without encapsulated enzymes showed lower lev-
els of water uptake. This phenomenon can be explained
by the fact that, once small amounts of water penetrate
the matrix, the enzyme is gradually dissolved and at the
same time diffuses from the matrix, creating microscopic
voids and leading to faster water penetration.
Water penetration will generate limited hydration and
swelling of the SPCL disk, and once small amounts of
water penetrate the matrix, a-amylase dissolves gradually
and its hydrolytic activity starts. The water uptake results
shown in Fig. 2B were obtained after 1 week at 37 #C. After
this time, there is already significant degradation of the
starch matrix for the disks with encapsulated enzyme
(Fig. 4). The higher water uptake observed for the loaded
disks might be due to the higher permeability of the matrix
caused by degradation.
Proteins that are encapsulated into polymeric matrices
can be denatured during the formulation, storage and
release, which can result in loss of its activity. Release
experiments were performed at 4 #C with loaded SPCL
disks and the activity of the released enzyme was deter-
mined (Fig. 3). It was found that the enzyme activity
reaches a plateau of 40% of its original activity by about
48 h, after which no further increase is observed. The
release rate at 4 #C might, however, be limited, being con-
trolled mainly by enzyme diffusion from the matrix. At
37 #C the release rate is expected to be higher due to the
effects of diffusion and degradation of the polymeric
matrix.
In the presence of a-amylase (encapsulated or free in
solution), the SPCL disks are degraded into water-soluble
sugars, resulting in disk weight loss (Fig. 4). The degrada-
tion of SPCL disks was shown to be dependent on the
Fig. 8. SEM micrographs of the surface of SPCL disks after degradation for 1, 4 and 12 weeks in PBS containing 0.5% (A) and 5% (B) a-amylase free in
solution.
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amount of enzyme encapsulated, being faster for disks with
higher amount of enzyme. These results indicate that the
degradation rate of the starch matrix can be controlled
by the amount of encapsulated a-amylase. The encapsula-
tion method therefore seems to be adequate for controlling
the degradation kinetics of starch-based biomaterials. The
absence of sugars in solution for the control samples (disk
without enzyme) for periods of time of up to 12 weeks also
shows that there was no thermodegradation of starch
matrix during processing (Fig. 4A). Comparing the degra-
dation pattern between encapsulated (Fig. 4A) and free
enzyme (Fig. 4B), no significant differences were observed.
This indicates that the enzyme did not lose its activity dur-
ing the preparation of the disks, revealing a non-denaturing
effect of the encapsulation technique on the enzyme activ-
ity. The similarity in the degradation patterns of the free
and encapsulated enzymes might indicate that after 1 week
the encapsulated enzyme has been completely released
from the SPCL disk; the results of weight loss and concen-
tration of the reducing sugars would thus be comparable to
those obtained for the enzyme free in solution. However,
the SEM images show a distinct degradation effect between
the encapsulated (Fig. 6) and free enzyme (Fig. 8). The
disks containing a-amylase entrap active enzyme in a lim-
ited space and thus the accessible reacting surface of the
starch matrix per enzyme is higher that when the enzyme
is free in solution. In the latter case, only a part of the
active enzyme is in contact with the external surface of
the matrix and it cannot penetrate more deeply in the disk.
5. Conclusions
This study investigated the potential of a novel
approach to control the degradation kinetics of a starch-
based biomaterial by encapsulating a starch-degrading
enzyme into the starch matrix using a thermomechanical
process. The results showed that by using a thermostable
enzyme it is possible to retain its activity during the encap-
sulation process, and the degradation of the starch matrix
can be controlled by encapsulating the proper amount of a-
amylase. Although a microbial enzyme was used in this
study, one must bear in mind that if implantation in the
human body is envisioned, enzymes from human origin
would be required to avoid an immune response. With
the advances in genetic engineering, it should be possible
to introduce internal thermostability in mesophilic enzymes
(e.g. human enzymes), which might in the future allow the
incorporation of human enzymes during the processing of
biomaterials under moderately high temperatures.
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